Overview

Psychological Impact of Amenorrhea in Women With Endometriosis

Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of the study is to evaluate the impact on quality of life, psychological health, sexuality and chronic pain of therapies which determine amenorrhea in symptomatic women with endometriosis, through the administration of self reported questionnaires. Amenorrhea in the first group is caused by balanced assumption of estroprogestins, in the second group is caused by GnRHa-induced hypoestrogenism.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Cagliari
Treatments:
Calcium Carbonate
Calcium, Dietary
Cholecalciferol
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Hormones
Leuprolide
Polyestradiol phosphate
Tibolone
Criteria
Inclusion Criteria:

- Clinical, echographical or surgical diagnosis of endometriosis

Exclusion Criteria:

- Comorbidity

- Psychiatric diseases

- Refusal or inability to sign informed consent